Global Gamma Knife Radiosurgery (GKRS) Market Strategic Research Report

Scope of the Report

The global Gamma Knife Radiosurgery (GKRS) market size is predicted to grow from US$ 188 million in 2025 to US$ 294 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

Gamma Knife Radiosurgery (GKRS) is a form of stereotactic radiosurgery that delivers many highly focused gamma-ray beams—classically from cobalt-60 (⁶⁰Co) sources—so that the beams converge on a defined intracranial target and create a high dose at the target while limiting dose to surrounding brain.

The upstream supply chain centers on sealed ⁶⁰Co sources and their regulated lifecycle (manufacture, encapsulation, transport, loading/replacement), plus high-density beam collimation and shielding structures.

Downstream, GKRS is installed and operated in hospital radiation oncology/neurosurgery programs as a dedicated intracranial radiosurgery platform. Typical clinical use includes small-to-medium brain lesions such as brain tumors (including metastases), arteriovenous malformations (AVMs), and selected functional disorders like trigeminal neuralgia; many centers also treat lesions near the upper spine depending on platform capability and protocols.

In 2025, global sales of Gamma Knife Radiosurgery (GKRS) reached approximately 52 units, with an average global market price of around US$ 3.7 million/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 35% to 45%.

Demand for Gamma Knife radiosurgery is fundamentally driven by the clinical value proposition in intracranial indications: extreme geometric precision, sharp dose fall-off, and non-invasive workflows that aim to preserve surrounding eloquent brain structures while achieving strong local control. As care pathways mature, providers increasingly prioritize throughput, planning speed, and patient comfort—pushing vendors to tighten integration across imaging, localization, planning, QA, and delivery, with more automation to reduce operator variability.

On the supply side, the category behaves like a premium, niche capital platform with long-tail service economics. Purchasing decisions are tightly coupled to center-of-excellence strategy, referral networks, specialist preference, and the hospital’s broader radiotherapy stack. Reliability, uptime, remote support, training ecosystems, and lifecycle upgrades matter as much as headline technical specs, which raises the bar for service capability and installed-base leverage.

Competition continues to intensify from linac-based SRS as those platforms improve in image guidance and adaptive capabilities, especially for hospitals seeking one platform to cover more anatomies and indications. Gamma Knife remains most defensible where intracranial precision, mature evidence, and streamlined cranial radiosurgery workflows are the priority. Overall, momentum is shaped by incremental improvements in planning efficiency, delivery confidence, and lower lifecycle uncertainty—rather than by a single disruptive leap.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gamma Knife Radiosurgery (GKRS) market?

What factors are driving Gamma Knife Radiosurgery (GKRS) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gamma Knife Radiosurgery (GKRS) market opportunities vary by end market size?

How does Gamma Knife Radiosurgery (GKRS) break out by Type, by Application?

This report presents a comprehensive overview of the global Gamma Knife Radiosurgery (GKRS) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Head Gamma Knife
• Body Gamma Knife

Segment by Treatment Scheduling

• Single-session GKRS
• Fractionated GKRS

Segment by Immobilization Workflow

• Stereoscopic X-ray Guidance
• Cone-beam CT (CBCT) Guidance
• Fiducial-based Image Guidance

Segment by Application

• Brain Stereotactic Radiosurgery
• Stereotactic Body Radiation Therapy (SBRT)

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gamma Knife Radiosurgery (GKRS) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Brain Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy (SBRT) evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact